Journal of Advances in Medicine and Medical Research

Association between N-terminal Pro-Brain Natriuretic Peptide and Acute Ischemic Stroke in Male Patients

Journal of Advances in Medicine and Medical Research, Volume 35, Issue 18, Page 1-8
DOI: 10.9734/jammr/2023/v35i185115

Abstract


Aims: Stroke is among the major cause of mortality and disability globally. Many types of research are ongoing in search of a reliable biomarker for acute ischemic stroke. This study was aimed to see the association of the serum N-terminal proBNP (pro-brain natriuretic peptide) or NT-proBNP with acute ischemic stroke.

Study Design: Case-control study.

Methodology: This case-control study was conducted from January 2023 to June 2023. A total of 30 acute ischemic stroke male patients were enrolled as cases with 30 healthy male controls. Serum NT-proBNP level was measured in all the participants. Clinical features including the National Institute of Health Stroke (NIHSS) scale score were recorded in cases.

Results: The mean ages of the cases and controls were 61 ± 9.22 and 62.40 ± 8.23 years respectively. Among the acute ischemic stroke patients, more than half of the patients (53%) had lacunar stroke. According to the NIHSS score, more than 90% of the patients had minor or moderate stroke (93.3%). The mean NT-proBNP of cases was significantly higher than the controls (266.99 ± 357.88 vs 46.32 ± 18.59) (P = .04). The mean logNT-proBNP level (1.96 ± 0.72) was also significantly higher among the cases than the controls (1.61 ± 0.22) (P = .04). We did not find any association of serum logNTpro-BNP with the duration of stroke (P = .40). There was also no statistically significant association between the NIHSS score and NT-proBNP or logNTpro-BNP levels (P = .36).

Conclusion: Serum NT-proBNP level was significantly higher in acute ischemic stroke patients. There was no association of NT-proBNP level with the stroke severity and duration.

Keywords:
  • Ischemic stroke
  • NT-proBNP
  • biomarker
  • stroke severity

How to Cite

Sultana, S. A., Huq, M. R., Malek, M. A., Kawnayn, G., Siddique, R., Haque, M. Z., Haque , D. M., Mila , N. Z., & Hanfa, N. (2023). Association between N-terminal Pro-Brain Natriuretic Peptide and Acute Ischemic Stroke in Male Patients. Journal of Advances in Medicine and Medical Research, 35(18), 1–8. https://doi.org/10.9734/jammr/2023/v35i185115

References

GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-1544. DOI: 10.1016/S0140-6736(16)31012-1.

Meyer BC, Lyden PD. The modified National Institutes of Health Stroke Scale: its time has come. Int J Stroke. 2009;4(4):267-73. DOI: 10.1111/j.1747-4949.2009.00294.x. PMID: 19689755; PMCID: PMC2729912.

Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843-9. DOI: 10.1136/hrt.2005.071233. PMID: 16698841; PMCID: PMC1860679.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem. 2006;52(8):1528-38.

DOI: 10.1373/clinchem.2006.069575. Epub 2006 Jun 15. PMID: 16777915.

Steiner J, Guglin M. BNP or NTproBNP? A clinician's perspective. Int J Cardiol. 2008 Sep 16;129(1):5-14. DOI: 10.1016/j.ijcard.2007.12.093. Epub 2008 Apr 18. PMID: 18378336.

Roch A. What does high NT-proBNP mean in septic shock patients? A part of the puzzle. Crit Care. 2007;11(2):122. DOI: 10.1186/cc5728. PMID: 17442126; PMCID: PMC2206461.

Chen X, Zhan X, Chen M, Lei H, Wang Y, Wei D, et al. The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke. Intern Med. 2012;51(20):2887-92.

DOI: 10.2169/internalmedicine.51.8027. Epub 2012 Oct 15. PMID: 23064562.

Tu WJ, Dong X, Zhao SJ, Yang DG, Chen H. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol. 2013;25(9):771-8. DOI: 10.1111/jne.12052. PMID: 23701638.

Okada Y, Terakawa Y, Murata T, Nakamura K, Shimotake K, Murata H, et al. Ability of NT-pro-BNP to Diagnose Cardioembolic Etiology in Patients with Acute Ischemic Stroke. Osaka City Med J. 2016;62(2):95-102.

PMID: 30721584.

Li J, Gu C, Li D, Chen L, Lu Z, Zhu L, et al. Effects of serum N-terminal pro B-type natriuretic peptide and D-dimer levels on patients with acute ischemic stroke. Pak J Med Sci. 2018 Jul-Aug;34(4):994-998.

DOI: 10.12669/pjms.344.15432. PMID: 30190768; PMCID: PMC6115578.

Agarwalla AK, Miah MB, Dey SK, Islam MR, Islam MZ, Hasan M, et al. Association of Plasma Brain Natriuretic Peptide with Severity of Acute Ischemic Stroke. Bangladesh Journal of Neuroscience. 2018;34(2):85-91.

DOI:/10.3329/bjn.v34i2.57552

Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991 Jun 22;337(8756):1521-6. doi: 10.1016/0140-6736(91)93206-o. PMID: 1675378.

Martínez Linares JM, Guisado Barrilao R, Ocaña Peinado FM, Salgado Parreño FJ. Association of cardiovascular emerging risk factors with acute coronary syndrome and stroke: A case-control study. Nurs Health Sci. 2016;18(4):488-495. DOI: 10.1111/nhs.12299. Epub 2016 Aug 11. PMID: 27510402.

Arslan BM, Cabalar M, Isiksacan N, Yayla V. Assessment of Relationship between Serum NT-proBNP Levels with Clinical Features and Prognosis in Acute Ischemic Stroke Patients. Neurol India. 2022 Nov-Dec;70(6):2401-2406. DOI: 10.4103/0028-3886.364072. PMID: 36537423.

Zhao J, Zhang Y, Yuan F, Song C, Jiang Y, Gao Q, et al. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study. J Neurol Sci. 2020;414:116822. DOI: 10.1016/j.jns.2020.116822. Epub 2020 Apr 6. PMID: 32278166.

Fonseca AC, Coelho P. Update on Biomarkers Associated to Cardioembolic Stroke: A Narrative Review. Life (Basel). 2021 May 17;11(5):448. DOI: 10.3390/life11050448. PMID: 34067554; PMCID: PMC8156147.

Jensen JK, Mickley H, Bak S, Korsholm L, Kristensen SR. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc Dis. 2006;22(5-6):439-44. DOI: 10.1159/000094997. Epub 2006 Aug 11. PMID: 16912478.

Zhao YH, Gao H, Pan ZY, Li J, Huang WH, Wang ZF, et al. Prognostic Value of NT-proBNP After Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Cohort Studies. J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104659. DOI: 10.1016/j.jstrokecerebrovasdis.2020.104659. Epub 2020 Feb 14. PMID: 32067852.

Shen X, Liao J, Jiang Y, Xu Y, Liu M, Zhang X, et al. Elevated NT-proBNP levels are associated with CTP ischemic volume and 90-day functional outcomes in acute ischemic stroke: A retrospective cohort study. BMC Cardiovasc Disord. 2022 Sep 30;22(1):431. DOI: 10.1186/s12872-022-02861-w. PMID: 36180827; PMCID: PMC9524121.

Bustamante A, Penalba A, Orset C, Azurmendi L, Llombart V, Simats A, et al. Blood Biomarkers to Differentiate Ischemic and Hemorrhagic Strokes. Neurology. 2021;96(15):e1928-e1939.

DOI: 10.1212/WNL.0000000000011742. Epub 2021 Mar 5. PMID: 33674361.

  • 33 times
    PDF Download: 8 times

Download Statistics

Downloads

Download data is not yet available.
Make a Submission

Information

Current Issue